Cardiovascular Phamacology Flashcards
(51 cards)
Antihypertensive Drugs
Hypertension
- Sustained, reproducible increase in blood pressure
- 15-20% of adult Americans are believed to be hypertensive
- If left untreated, the sustained increase in blood pressure can lead to cardiovascular problems (stroke, HF), renal disease, and blindness
- ‘Silent killer’ – asymptomatic
- Morbidity and mortality is due to the end organ damage
Antihypertensive Drugs
Normal Control of BP
- Short-term = baroreceptor reflex
- Long-term management = kidneys
- BP is a product of cardiac output and the total resistance in the peripheral vasculature
- BP = (CO) x (TPR)
Antihypertensive drugs
Pathogenesis of Hypertension
Two major categories
•Primary, or essential, hypertension
–No know cause
–Genetic and environmental factors
–General increase in sympathetic activity
•Secondary
–Renal artery stenosis
–Pheochromocytoma
–Aortic coarctation
–Adrenal tumor
Pharmacological Therapy used primarily for essential hypertension
Baroreflexes
1)MAP= set point
2)Reflexes defend set point
1)Arterial Baroreflexes
2)Pressure/Natriuresis
3)Change in MAP opposed by reflex response to maintain set pressure.
4)Hypertension- pressure resets to higher level-defended by reflex systems.
●
CRITICAL POINT!
**Multiple therapies often needed to block reflex compensation.
Treatment Strategy of Hypertension
•Goal- normalize pressure- decrease CO and/or TPR
•Strategy- alter volume, cardiac and/or VSM function
•Diagnosis = 3-6 independent measurements
•Determination of primary vs. secondary HTN
•If secondary
–Treat underline pathology
•If primary
–Initiate lifestyle changes
–Pharmacological treatment
Pharmacological Treatment
- Diuretics
- Alpha-1 antagonists
- Alpha-2 agonists
- Beta adrenergic antagonists
- Anti-angiotensin II receptor blockers
- Ca2+ channel blockers
- Vasodilators
Diuretics
Often the first type of drugs to treat hypertension
Site of action
–Renal nephron
MOA
–Increase renal excretion of water and sodium => decrease the volume of fluid within the vascular system
Effect on cardiovascular system
–Acute decrease in CO
–Chronic decrease in TPR, normal CO
Classification of Diuretics
•Thiazide diuretics
–chlorothiazide (Diuril®), hydrochlorothiazide (Hydrodiuril®)
–Act primarily on the early portion of the distal tubule of the nephron => inhibit Na+ reabsorption
•Loop diuretics
–bumetanide (Bumex®), furosemide (Lasix®), metolazone (Zaroxolyn®)
–Act primarily on the ascending limb of the loop of Henle => inhibit Na+ reabsorption
•Potassium-sparing diuretics
–amiloride (Midamor); spironolactone (Aldactone); triamterene (Dyrenium)
–Prevent K+ secretion into the distal tubule (prevent hypokalemia)
•Osmotic diuretics
–mannitol (Osmitrol); urea (Ureaphil)
–Act in renal proximal tubule => prevent H2O reabsorption
–Extract H2O from systemic body compartments => expanded extracellular fluid volume and increases renal blood flow
Adverse Effects of Diuretics
•Fluid depletion
–May cause reflex ↑ in CO and PVR because of activation of baroreflex => excessive demand on the myocardium in certain CHF pts
•Electrolyte imbalances
–Sodium depletion (hyponatremia)
–Potassium depletion (hypokalemia)
- Orthostatic hypotension
- GI disturbances
- Weakness/fatigue
- Confusion
Therapeutic Considerations for Diuretics
•Thiazides (most common diuretics for HTN)
–Generally start with lower potency diuretics
–Generally used to treat mild to moderate HTN
–Use with lower dietary Na+ intake, and K+ supplement or high K+ food
- K+ Sparing (combination with other agent)
- Loop diuretics (severe HTN, or with CHF)
- Osmotic (HTN emergencies)
•Maximum antihypertensive effect reached before maximum diuresis- 2nd agent indicated
Alpha-1 Adrenergic Antagonist
doxazosin (Cardura®), prazosin (Minipress®), terazosin (Hytrin®)
•Site of action
–Peripheral arterioles
–Smooth muscle
•MOA
–Competitive antagonist at a-1 receptors on vascular smooth muscle
•Effects on cardiovascular system
–Vasodilation, reduces peripheral resistance
- Blocking a-receptors on vascular smooth muscle allows muscle relaxation, dilation of vessel, and reduced resistance
- S/E: reflex tachycardia, orthostatic hypotension
Therapeutic Considerations for alpha 1 adrenergic antagonist
- No reflex tachycardia; small 1st dose
- Does not impair exercise tolerance
- Useful with diabetes, asthma, and/or hypercholesterolemia
- Use in mild to moderate hypertension
- Often used with diuretic, b antagonist
Central Sympatholytics (a-2 Agonists)
clonidine (Catapres), methyldopa (Aldomet)
•Site of action
–CNS medullary cardiovascular centers
–clonidine; direct a-2 agonist
–methyldopa: “false neurotrans.”
•MOA
–CNS a-2 adrenergic stimulation
–Peripheral sympathoinhibition
–Decreased norepinephrine release
•Effect on cardiovascular system
–Decreased NE–>vasodilation–> Decreased TPR
- Stimulation of a-2 receptors in the medulla decreases peripheral sympathetic activity, reduces tone, vasodilation and decreases TPR
- S/Es: dry mouth, sedation, impotence
ß Adrenergic Antagonists
labetalol (Normodyne); propranolol (Inderal); metoprolol (Lopressor); atenolol (Tenormin); nadolol (Corgard)
•Site of action
–Heart
•MOA
–Competitive antagonist at b- adrenergic receptors
•Effect on cardiovascular system
–Cardiac– ß HR, ¯ SVÞ ß CO
–Renal– ß Renin Þ ß Angiotensin II Þ ß TPR
- S/Es: impotence; bradycardia; fatigue; exercise intolerance
- Contraindications: asthma; diabetes; bradycardia; hypersensitivity
Therapeutic Considerations for Beta Adrenergic Antagonists
•Selectivity
–nadolol (Corgard) non selective, but 20 hr 1/2 life
–metoprol (Lopresor) b-1 selective, 3-4 hr 1/2 life
- Risky in pulmonary disease even selective b-1
- Available as mixed a/b blocker available-labetalol (Trandate, Normodyne)
- Use post myocardial infarction- protective
- Use with diuretic- prevent reflex tachycardia
Anti-Angiotensin II Drugs
Angiotensin Converting Enzyme (ACE) Inhibitors
•enalopril (Vasotec);
•quinapril (Accupril);
•fosinopril (Monopril);
•lisinopril (Zestril, Prinivil);
•benazepril (Lotensin);
•captopril (Capoten)
Angiotensin Receptor Blockers (ARBs)
- losartan (Cozaar);
- candesartan (Atacand);
- valsartan (Diovan)
Anti-Angiotensin II Drugs Effects
•Effect on cardiovascular system
–↓ volume => ↓CO
–↓ HR => ↓SV => ↓SNS => ↓CO
–↓ Angiotensin II => ↓SNS => ↓CO
- S/Es: hyperkalemia, angiogenic edema (ACE inhib); cough (ACE inhib); rash; itching
- Contraindications: pregnancy; hypersensitivity; bilateral renal stenosis
Therapeutic Considerations for Anti-Angiotensin II
- Use with diabetes or renal insufficiency
- Adjunctive therapy in heart failure
- Often used with diuretic
- Enalapril, iv for hypertensive emergency
Calcium Channel Blockers
•verapamil (Calan); nifedipine (Procardia); diltiazem (Cardizem); amlodipine (Norvasc)
•Site of action
–Vascular smooth muscle
•MOA
–Blocks Ca++ channel decreases/prevents contraction
•Effect on cardiovascular system
–Vascular relaxation
–Decreased TPR
- S/Es: nifedipine –Increase SymNS activity; headache; dizziness; peripheral edema
- Contraindications: Congestive heart failure; pregnancy and lactation; Post-myocardial infarction
Therapeutic Consideration for Calcium Channel Blockers
- Verapamil- mainly cardiac; interactions w/ cardiac glycosides
- Nifedipine- mainly arterioles
- Diltiazem-both cardiac and arterioles at high doses, AV node block may occur;
- Nifedipine may increase heart rate (reflex)
Vasodilators
hydralazine (Apresoline); minoxidil (Loniten); nitroprusside (Nipride); diazoxide (Hyperstat I.V.); fenoldopam (Corlopam)
•Site of action
–vascular smooth muscle
•MOA
–Systemic vascular vasodilation
- hydralazine- alters intracellular calcium, increases nitric oxide in arterioles
- minoxidil- opens K+ channels on arteriolar membranes, stabilizes membrane
- nitroprusside- induces nitric oxide from endothelial cells (arterioles and veins)
- diazoxide- opens K+ channels, stabilizes membrane (arterioles)
•fenoldopam- activates dopamine(D1) receptors on VSM (arterioles)
–Low doses dopamine stimulates primarily dopamine receptors- Vasodilation
–Higher doses- stimulates B1 receptors- positive inotropic effect
–Increases CO
–Also releases NE from vascular nerve terminals– vasoconstriction
Vasodilators Effects, S/E, Therapeutic Considerations
•Effects on cardiovascular system
–vasodilation, decrease TPR
•S/E: reflex tachycardia, Increase SymNS activity (hydralazine, minoxidil,diazoxide), lupus (hydralazine), hypertrichosis (minoxidil), cyanide toxicity (nitroprusside)
•Therapeutic Considerations
–nitroprusside- iv only
–hydralazine- safe for pregnancy
–diazoxide- emergency use for severe hypertension
Concerns in Rehab Patients Vasodilators
- Side effects such as hypotension and orthostatic hypotension => caution with change posture or activities that may lower BP
- Avoid or caution with activities that produce vasodilation esp. if vasodilating agents are used
- Exercise may cause vasodilation in skeletal musculature which may potentiate the effect of vasodilation induced by alpha blockers, CCBs, or direct acting vasodilators
- Stress the importance of compliance
- Suggest nonpharmacologic methods of lowering blood pressure (stress management, relaxation techniques, exercise programs)
Hyperlipidemia
•Hyperlipidemia, hyperlipoproteinemia, or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood
- Lipids are insoluble in aqueous solution
- Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism
•Lipid and lipoprotein abnormalities are extremely common in the general population, and are regarded as a highly modifiable risk factor for cardiovascular disease due to the influence of cholesterol, one of the most clinically relevant lipid substances, on artherosclerosis Additionally, some forms may predispose to acute pancreatitis
